世界の滅菌バイアル市場2021年-2031年：製品別（滅菌空バイアル、滅菌液体充填バイアル、個別滅菌コンポーネント [ISC]）、容量別、材料別、エンドユーザー別

• 英文タイトル：Sterile Vials Market (Product: Sterile Empty Vial, Sterile Liquid Filled Vial, and Individual Sterilized Components [ISCs]; Volume: <2ml, 2 ml to 5 ml, 5 ml to 10 ml, 10 ml to 20 ml, and >20ml; Material: Glass and Plastic; and End User: Clinical Labs, Compounding Labs, Biopharmaceutical Companies, CMOs, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

• レポートコード：MRC2106B031 • 出版社/出版日：Transparency Market Research / 2021年4月3日 • レポート形態：英文、PDF、289ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Site Licence	￥1,301,660 (USD8,795)	▷ お問い合わせ
Enterprise Licence	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査レポートは、世界の滅菌バイアル市場について調査し、序論、仮定/調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品別（滅菌空バイアル、滅菌液体充填バイアル、個別滅菌コンポーネント [ISC]）分析、容量別分析、材料別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを徹底分析したものです。 ・序論 ・仮定/調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・世界の滅菌バイアル市場規模：製品別（滅菌空バイアル、滅菌液体充填バイアル、個別滅菌コンポーネント [ISC]） ・世界の滅菌バイアル市場規模：容量別 ・世界の滅菌バイアル市場規模：材料別 ・世界の滅菌バイアル市場規模：エンドユーザー別 ・世界の滅菌バイアル市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況

Sterile Vials Market – Scope of the Report

TMR’s report on the global sterile vials market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global sterile vials market for the period 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global sterile vials market for the forecast period of 2021–2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the sterile vials market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomena in the global sterile vials market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the sterile vials market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global sterile vials market.

The report delves into the competitive landscape of the global sterile vials market. Key players operating in the sterile vials market have been identified and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the sterile vials market profiled in this report.

Key Questions Answered in Sterile Vials Market Report

How does the development of sterile vials provide scope of growth of the global sterile vials market?
How alliances and partnerships between players are widening the scope of new line of technologies for sterile vials?
What are the revenue share projections of key segments under various criteria in the sterile vials market during the forecast period?
Which segment is likely to register leading revenue until the end of the forecast period in 2031?
Sterile Vials Market – Research Objectives and Research Approach

The comprehensive report on the global sterile vials market begins with an overview of the market, followed by the scope and objectives of this study. The report also provides detailed explanation of the objectives behind this study and healthcare compliances laid down by accredited agencies in the purview of line of procedure for sterile vials.

For reading comprehensibility, the report is compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the sterile vials market in terms of product, volume, material, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global sterile vials market.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sterile Vials Market
4. Market Overview
4.1. Introduction
4.1.1. Market Introduction
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Global Sterile Vials Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
5. Key Insights
5.1. Recent Development (industry updates, merger & acquisitions)
5.2. Key Vendor and Distributor Analysis
5.3. Sterile Vials Pricing Analysis
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Sterile Vials Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value and Volume Forecast by Product, 2017–2031
6.3.1. Sterile Empty Vial
6.3.1.1. Sterile Evacuated Vial
6.3.1.2. Sterile Nitrogen Filled Vial
6.3.1.3. Sterile Air Filled Vial
6.3.2. Sterile Liquid Filled Vial
6.3.2.1. Sterile Saline Filled Vial
6.3.2.2. Sterile Media Filled Vial
6.3.2.3. Sterile Water Filled Vial
6.3.3. Individual Sterilized Components (ISCs)
6.4. Market Attractiveness Analysis, by Product
7. Global Sterile Vials Market Analysis and Forecast, by Volume
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value and Volume Forecast, by Volume, 2017–2031
7.3.1. <2ml 7.3.2. 2 ml to 5ml 7.3.3. 5 ml to 10 ml 7.3.4. 10 ml to 20 ml 7.3.5. >20ml
7.4. Market Attractiveness Analysis, by Volume
8. Global Sterile Vials Market Analysis and Forecast, by Material
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Material, 2017–2031
8.3.1. Glass
8.3.2. Plastic
8.4. Market Attractiveness Analysis, by Material
9. Global Sterile Vials Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value and Volume Forecast, by End-user, 2017–2031
9.3.1. Clinical Labs
9.3.2. Compounding Labs
9.3.3. Biopharmaceutical Companies
9.3.4. CMOs
9.3.5. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Sterile Vials Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value and Volume Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Sterile Vials Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value and Volume Forecast, by Product, 2017–2031
11.2.1. Sterile Empty Vial
11.2.1.1. Sterile Evacuated Vial
11.2.1.2. Sterile Nitrogen Filled Vial
11.2.1.3. Sterile Air Filled Vial
11.2.2. Sterile Liquid Filled Vial
11.2.2.1. Sterile Saline Filled Vial
11.2.2.2. Sterile Media Filled Vial
11.2.2.3. Sterile Water Filled Vial
11.2.3. Individual Sterilized Components (ISCs)
11.3. Market Value and Volume Forecast, by Volume, 2017–2031
11.3.1. <2ml 11.3.2. 2 ml to 5ml 11.3.3. 5 ml to 10 ml 11.3.4. 10 ml to 20 ml 11.3.5. >20ml
11.4. Market Value & Volume Forecast, by Material, 2017–2031
11.4.1. Glass
11.4.2. Plastic
11.5. Market Value and Volume Forecast, by End-user, 2017–2031
11.5.1. Clinical Labs
11.5.2. Compounding Labs
11.5.3. Biopharmaceutical Companies
11.5.4. CMOs
11.5.5. Others
11.6. Market Value and Volume Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Volume
11.7.3. By Material
11.7.4. By End-user
11.7.5. By Country
12. Europe Sterile Vials Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value and Volume Forecast, by Product, 2017–2031
12.2.1. Sterile Empty Vial
12.2.1.1. Sterile Evacuated Vial
12.2.1.2. Sterile Nitrogen Filled Vial
12.2.1.3. Sterile Air Filled Vial
12.2.2. Sterile Liquid Filled Vial
12.2.2.1. Sterile Saline Filled Vial
12.2.2.2. Sterile Media Filled Vial
12.2.2.3. Sterile Water Filled Vial
12.2.3. Individual Sterilized Components (ISCs)
12.3. Market Value and Volume Forecast, by Volume, 2017–2031
12.3.1. <2ml 12.3.2. 2 ml to 5ml 12.3.3. 5 ml to 10 ml 12.3.4. 10 ml to 20 ml 12.3.5. >20ml
12.4. Market Value & Volume Forecast, by Material, 2017–2031
12.4.1. Glass
12.4.2. Plastic
12.5. Market Value and Volume Forecast, by End-user, 2017–2031
12.5.1. Clinical Labs
12.5.2. Compounding Labs
12.5.3. Biopharmaceutical Companies
12.5.4. CMOs
12.5.5. Others
12.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Volume
12.7.3. By Material
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Sterile Vials Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value and Volume Forecast, by Product, 2017–2031
13.2.1. Sterile Empty Vial
13.2.1.1. Sterile Evacuated Vial
13.2.1.2. Sterile Nitrogen Filled Vial
13.2.1.3. Sterile Air Filled Vial
13.2.2. Sterile Liquid Filled Vial
13.2.2.1. Sterile Saline Filled Vial
13.2.2.2. Sterile Media Filled Vial
13.2.2.3. Sterile Water Filled Vial
13.2.3. Individual Sterilized Components (ISCs)
13.3. Market Value and Volume Forecast, by Volume, 2017–2031
13.3.1. <2ml 13.3.2. 2 ml to 5ml 13.3.3. 5 ml to 10 ml 13.3.4. 10 ml to 20 ml 13.3.5. >20ml
13.4. Market Value & Volume Forecast, by Material, 2017–2031
13.4.1. Glass
13.4.2. Plastic
13.5. Market Value and Volume Forecast, by End-user, 2017–2031
13.5.1. Clinical Labs
13.5.2. Compounding Labs
13.5.3. Biopharmaceutical Companies
13.5.4. CMOs
13.5.5. Others
13.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Volume
13.7.3. By Material
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Sterile Vials Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value and Volume Forecast, by Product, 2017–2031
14.2.1. Sterile Empty Vial
14.2.1.1. Sterile Evacuated Vial
14.2.1.2. Sterile Nitrogen Filled Vial
14.2.1.3. Sterile Air Filled Vial
14.2.2. Sterile Liquid Filled Vial
14.2.2.1. Sterile Saline Filled Vial
14.2.2.2. Sterile Media Filled Vial
14.2.2.3. Sterile Water Filled Vial
14.2.3. Individual Sterilized Components (ISCs)
14.3. Market Value and Volume Forecast, by Volume, 2017–2031
14.3.1. <2ml 14.3.2. 2 ml to 5ml 14.3.3. 5 ml to 10 ml 14.3.4. 10 ml to 20 ml 14.3.5. >20ml
14.4. Market Value & Volume Forecast, by Material, 2017–2031
14.4.1. Glass
14.4.2. Plastic
14.5. Market Value and Volume Forecast, by End-user, 2017–2031
14.5.1. Clinical Labs
14.5.2. Compounding Labs
14.5.3. Biopharmaceutical Companies
14.5.4. CMOs
14.5.5. Others
14.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Volume
14.7.3. By Material
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Sterile Vials Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value and Volume Forecast, by Product, 2017–2031
15.2.1. Sterile Empty Vial
15.2.1.1. Sterile Evacuated Vial
15.2.1.2. Sterile Nitrogen Filled Vial
15.2.1.3. Sterile Air Filled Vial
15.2.2. Sterile Liquid Filled Vial
15.2.2.1. Sterile Saline Filled Vial
15.2.2.2. Sterile Media Filled Vial
15.2.2.3. Sterile Water Filled Vial
15.2.3. Individual Sterilized Components (ISCs)
15.3. Market Value and Volume Forecast, by Volume, 2017–2031
15.3.1. <2ml 15.3.2. 2 ml to 5ml 15.3.3. 5 ml to 10 ml 15.3.4. 10 ml to 20ml 15.3.5. >20ml
15.4. Market Value & Volume Forecast, by Material, 2017–2031
15.4.1. Glass
15.4.2. Plastic
15.5. Market Value and Volume Forecast, by End-user, 2017–2031
15.5.1. Clinical Labs
15.5.2. Compounding Labs
15.5.3. Biopharmaceutical Companies
15.5.4. CMOs
15.5.5. Others
15.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Volume
15.7.3. By Material
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competitive Landscape
16.1. Market Player – Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. Adelphi Healthcare Packaging (The Adelphi Group Of Companies)
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. APG Europe
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. Bormioli Pharma S.p.a.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. Corning Incorporated
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Dalton Pharma Services
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. DWK Life Sciences GmbH
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. Gerresheimer AG
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Nipro Corporation
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. O.Berk Company
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis
16.2.10. Pacific Vial
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Financial Overview
16.2.10.3. Product Portfolio
16.2.10.4. Strategic Overview
16.2.10.5. SWOT Analysis
16.2.11. Piramal Glass (Piramal Enterprises Ltd.)
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Financial Overview
16.2.11.3. Product Portfolio
16.2.11.4. Strategic Overview
16.2.11.5. SWOT Analysis
16.2.12. Schott AG
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Financial Overview
16.2.12.3. Product Portfolio
16.2.12.4. Strategic Overview
16.2.12.5. SWOT Analysis
16.2.13. SDG Pharma
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Financial Overview
16.2.13.3. Product Portfolio
16.2.13.4. Strategic Overview
16.2.13.5. SWOT Analysis
16.2.14. Shandong Pharmaceutical Glass Co. Ltd.
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Financial Overview
16.2.14.3. Product Portfolio
16.2.14.4. Strategic Overview
16.2.14.5. SWOT Analysis
16.2.15. SiO2 Materials Science
16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.15.2. Financial Overview
16.2.15.3. Product Portfolio
16.2.15.4. Strategic Overview
16.2.15.5. SWOT Analysis
16.2.16. Stevanato Group
16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.16.2. Financial Overview
16.2.16.3. Product Portfolio
16.2.16.4. Strategic Overview
16.2.16.5. SWOT Analysis
16.2.17. Thermo Fisher Scientific, Inc.
16.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.17.2. Financial Overview
16.2.17.3. Product Portfolio
16.2.17.4. Strategic Overview
16.2.17.5. SWOT Analysis
16.2.18. West Pharmaceutical Services, Inc.
16.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.18.2. Financial Overview
16.2.18.3. Product Portfolio
16.2.18.4. Strategic Overview
16.2.18.5. SWOT Analysis

---